ClinicalTrials.Veeva

Menu

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU (SORCERER)

A

Azienda Usl di Bologna

Status

Enrolling

Conditions

Quality of Life
Tracheostomy Complication

Treatments

Procedure: Percutaneous tracheostomy

Study type

Observational

Funder types

Other

Identifiers

NCT06552676
SORCERER - 24088

Details and patient eligibility

About

Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy.

Participant Population/Primary Condition: Patients admitted to Intensive Care

Main Questions Aims to Answer:

    • What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy?
    • How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life?

Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons.

At the two-year follow-up, the health-related quality of life will be assessed

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age greater than 18 years
  • Presence of indication for tracheostomy

Exclusion criteria

  • Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy

Trial design

300 participants in 1 patient group

Percutaneous tracheostomy
Description:
Patients receiving percutaneous tracheostomy for any reason during their ICU stay
Treatment:
Procedure: Percutaneous tracheostomy

Trial contacts and locations

1

Loading...

Central trial contact

Lorenzo Gamberini, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems